Inactive disease | Low Activity | High Activity | Very High Activity | p-value | |
---|---|---|---|---|---|
Number of subjects | 6 | 15 | 27 | 13 | - |
Age (years) | 40 ± 11 | 39 ± 10 | 42 ± 10 | 38 ± 8 | 0.67 |
ESR (mm/hr) | 10 [2–13] | 8 [6–14] | 20 [11–31] | 41 [31–59] | < 0.01 |
CRP (mg/L) | 2 [2–2] | 2 [2–2] | 2.4 [2-9.1] | 36.2 [7.2–43] | < 0.01 |
Subfatin (ng/mL) | 0.5 [0.4–1.8] | 0.7 [0.4–1.1] | 0.6 [0.5–0.9] | 0.8 [0.4–1.4] | 0.82 |
CTHRC1 (ng/mL) | 55 [40–162] | 65 [39–95] | 55 [39–84] | 51 [47–125] | 0.98 |
CTRP3 (ng/mL) | 1.7 [1.6-3] | 2 [1.8–2.4] | 1.9 [1.7–2.1] | 1.9 [1.8-3] | 0.81 |
CTRP6 (ng/mL) | 0.9 [0.4–4.5] | 1.9 [1.4–2.9] | 2.1 [1.4–2.6] | 2.22 [1.6–5.9] | 0.48 |
IL-6 (pg/mL) | 89 [69–232] | 73[51–82] | 71 [58–79] | 69 [51–135] | 0.45 |
IL-17 (pg/mL) | 17 [15–60] | 28 [19–45] | 19 [15–33] | 26 [21–55] | 0.35 |
TNF-alpha (pg/mL) | 110 [83–168] | 98 [83–142] | 96 [80–129] | 106 [94–146} | 0.96 |
BASDAI (0–10) | 1.8 [1.7–2.8] | 2.2 [1.6–3.2] | 4.5 [2.8–5.6] | 4.3 [2.8–6.4] | < 0.01 |
BASFI (0–10) | 0 [0-0.6] | 1 [0-3.1] | 2.6 [1–5] | 3.4 [2.4-7] | < 0.01 |
BASMI (0–10) | 1 [0–2] | 0 [0–2] | 1 [0–4] | 4 [0–7] | 0.15 |
MASES (0–13) | 1 [0–1] | 0 [0–3] | 2 [0–5] | 0 [0–3] | 0.64 |
ASDAS-CRP | 1 [0.7-1] | 1.9 [1.6-2] | 2.6 [2.3-3] | 3.9 [3.7–4.1] | < 0.01 |
ASDAS-ESH | 1.2 [0.7–1.2] | 1.8 [1.5–2.3] | 2.9 [2.4–3.2] | 3.8 [3.6–4.1] | < 0.01 |